Date Filer Title Filing Type Shares Traded Price Total Held
May 12, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 585,191
Feb 18, 2020
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 290,000
Apr 01, 2021
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Apr 01, 2021
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Apr 01, 2021
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Oct 01, 2018
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 256,540 -- 256,540
Aug 23, 2018
Chief Scientific Officer
Chief Scientific Officer Form 4 Conversion of derivative security 254,275 -- --
Jun 14, 2023
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 250,000
Jun 14, 2023
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 250,000
Jun 14, 2023
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 -- 250,000

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.